CLINICAL STUDY ON SULBACTAM/CEFOPERAZONE IN THE TREATMENT OF RESPIRATORY TRACT INFECTION
1984 Volume 32 Issue Supplement4 Pages 288-292
Details
1984 Volume 32 Issue Supplement4 Pages 288-292
Sulbactam/Cefoperazone was administered to 11 episodes of 10 patients with respiratory tract infection.
The clinical effectiveness was good in 10 and fair 1. The clinical effective rate was 91%.
The causative organisms were able to isolate in 10 episodes: Haemophilus influenzae; 7 episodes, Streptococccus pneumoniae+Haemophilus influenzae; 1 episode and Staphylococcus aureus; 2 episodes. These organisms didn't yield after administration of sulbactam/cefoperazone without two episodes isolated β-lactamase produced Staphylococcus aureus. As side effects, two cases showed slight elevation of GOT and GPT, and one case showed slight elevation of Creatimine in serum.
